1. Cytokine and microbial profiles in relation to the clinical outcome following treatment of peri-implantitis
- Author
-
Cecilia Widén, Rutger Persson, and Stefan Renvert
- Subjects
Adult ,Male ,0301 basic medicine ,Peri-implantitis ,Aggregatibacter ,medicine.medical_treatment ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,Humans ,Tannerella forsythia ,Parvimonas micra ,Leptotrichia buccalis ,Bacteria ,biology ,Gingival Crevicular Fluid ,030206 dentistry ,biology.organism_classification ,Actinomyces israelii ,Peri-Implantitis ,Bacterial Load ,Vascular endothelial growth factor ,Treatment Outcome ,030104 developmental biology ,Cytokine ,chemistry ,Immunology ,Cytokines ,Female ,Oral Surgery - Abstract
Aim To study whether cytokine levels and bacterial counts in p atients with peri-implantitis reflect clinical treatment outcome following non-surgical management. Materials and Methods Luminex magnet bead technology and checkerboard DNA–DNA hybridization were used to assess treatment outcome after treatment at the implant with the most severe peri-implantitis in 41 participants. Results Study group mean age was 40.3 years (SD ± 9.9). Stable treatment outcome after 6 months (no further bone loss, probing pocket depth decrease ≥0.5 mm, no bleeding/suppuration) was identified in 9 of 41 (22%) participants. Peri-implant crevicular fluid (PICF) levels were also lower for Il-1β (P
- Published
- 2016